Our Journey

Since its founding in 2022, BryoSphere Biotechnologies has achieved key milestones, including securing investment from IndieBio and doubling that support through non-dilutive programs such as IRAP, SR&ED, and Mitacs. The company has filed a PCT patent protecting the only scalable method to produce its lead ingredient, BryoBright, and successfully scaled moss production to 10 L photobioreactors, transferring operations to the Vershuren Centre in Nova Scotia to initiate commercial scale-up. BryoSphere has also established strong relationships with leading skincare brands, with several awaiting third-party validation data as the company advances toward market readiness.

• Launched BryoBright, our moss-derived extract for hyperpigmentation.

• Began pilot scale up at the Verschuren Centre in Nova Scotia!
   
• Filed a PCT patent protecting our breakthrough process for commercially feasible moss bioactives.

•  Joined IndieBio Cohort 1 of 2024.
   
• Filed key patents and expanded production capacity.
   
• Achieved early market validation with strong interest from leading skincare brands.
   
• Welcomed Sheree Wiener, a seasoned beauty industry leader, as a strategic advisor.

•  Expanded laboratory capabilities.

• Engineered our first moss-based actives. 

•  Expanded our advisory team with Karen Boodram, MBA (life sciences commercialization) and Anthony Marotta, Ph.D. (biotech entrepreneurship and biomarker innovation).  

•  Founded BryoSphere Biotechnologies!
   
• Secured first grant.

• Joined entrepreneurship@UBC .